Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

The study created a skin model with realistic blood vessels that improves skin grafts and testing for drug delivery.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

A woman with lupus and severe nerve damage improved with specific treatments.

Adding a small amount of TPGS to minoxidil can help hair growth, but too much TPGS reduces this effect and increases minoxidil in the blood.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Effective treatments for severe alopecia areata are still lacking.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Systemic photodynamic therapy can effectively treat stubborn folliculitis decalvans with few side effects.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.